No Data
No Data
No Data
No Data
No Data
Investors Don't See Light At End Of Compugen Ltd.'s (NASDAQ:CGEN) Tunnel And Push Stock Down 26%
Compugen Ltd. (NASDAQ:CGEN) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month.
Simply Wall StApr 28 20:24
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer With Liver Metastases at ASCO 2024
HOLON, Israel, April 25, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE:CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced
PR NewswireApr 25 19:00
Compugen Reports Publication Of Paper In Cancer Immunology Research Demonstrating Therapeutic Potential Of COM503
Compugen Reports Publication Of Paper In Cancer Immunology Research Demonstrating Therapeutic Potential Of COM503
BenzingaApr 10 19:02
Compugen to Participate in Two Upcoming Investor Conferences
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...
PR NewswireApr 3 19:00
Truist Financial Reaffirms Their Buy Rating on Compugen (CGEN)
TipRanksMar 15 19:08
Are You Looking for a Top Momentum Pick? Why Compugen (CGEN) Is a Great Choice
Yahoo FinanceMar 13 00:00
No Data
No Data